Mohammed Lamorde, Infectious Diseases Institute, and Saye Khoo, University of Liverpool, discuss the Dolphin 2 Study, looking at Dolutegravir vs. Efavirenz based anti-retroviral therapy to reduce viral load of women in late pregnancy.
Mohammed Lamorde, Infectious Diseases Institute, and Saye Khoo, University of Liverpool, discuss the Dolphin 2 Study, looking at Dolutegravir vs. Efavirenz based anti-retroviral therapy to reduce viral load of women in late pregnancy.